|
|
|
Volumn 23, Issue 5 SUPPL. 11, 1996, Pages 16-22
|
|
A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DOXORUBICIN;
PACLITAXEL;
ADULT;
ADVANCED CANCER;
AGED;
ANTINEOPLASTIC ACTIVITY;
ARTHRALGIA;
ARTICLE;
BREAST CANCER;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MYALGIA;
NEUTROPENIA;
PERIPHERAL NEUROPATHY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
ADULT;
AGED;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ARTHRALGIA;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOXORUBICIN;
FEMALE;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HEART;
HUMANS;
INFUSIONS, INTRAVENOUS;
INJECTIONS, INTRAVENOUS;
MIDDLE AGED;
MUSCULAR DISEASES;
NEUTROPENIA;
PACLITAXEL;
PAIN;
PERIPHERAL NERVOUS SYSTEM DISEASES;
REMISSION INDUCTION;
STROKE VOLUME;
VENTRICULAR FUNCTION, LEFT;
|
|
EID: 0029808657
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (36)
|
|
References (0)
|
